RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Innocan Pharma Stock

Innocan Pharma Equity 2024

Innocan Pharma Equity

4.1 M USD

Ticker

INNO.CN

ISIN

CA45783P1027

WKN

A2PSPW

In 2024, Innocan Pharma's equity was 4.1 M USD, a -35.83% increase from the 6.39 M USD equity in the previous year.

Innocan Pharma Aktienanalyse

What does Innocan Pharma do?

Innocan Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Innocan Pharma's Equity

Innocan Pharma's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Innocan Pharma's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Innocan Pharma's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Innocan Pharma's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Innocan Pharma’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Innocan Pharma stock

What is the equity of Innocan Pharma this year?

Innocan Pharma has equity of 4.1 M USD this year.

What was the equity of Innocan Pharma compared to the previous year?

The equity of Innocan Pharma has increased/decreased by -35.83% decreased compared to the previous year.

What impact does a high equity have on investors of Innocan Pharma?

A high equity is advantageous for investors of Innocan Pharma as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Innocan Pharma?

A low equity can be a risk for investors of Innocan Pharma, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Innocan Pharma affect the company?

An increase in equity of Innocan Pharma can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Innocan Pharma affect the company?

A reduction in equity of Innocan Pharma can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Innocan Pharma?

Some factors that can affect the equity of Innocan Pharma include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Innocan Pharma so important for investors?

The equity of Innocan Pharma is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Innocan Pharma take to change the equity?

To change equity, Innocan Pharma can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Innocan Pharma pay?

Over the past 12 months, Innocan Pharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Innocan Pharma is expected to pay a dividend of 0 USD.

What is the dividend yield of Innocan Pharma?

The current dividend yield of Innocan Pharma is .

When does Innocan Pharma pay dividends?

Innocan Pharma pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Innocan Pharma?

Innocan Pharma paid dividends every year for the past 0 years.

What is the dividend of Innocan Pharma?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Innocan Pharma located?

Innocan Pharma is assigned to the 'Health' sector.

Wann musste ich die Aktien von Innocan Pharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Innocan Pharma from 11/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/1/2024.

When did Innocan Pharma pay the last dividend?

The last dividend was paid out on 11/1/2024.

What was the dividend of Innocan Pharma in the year 2023?

In the year 2023, Innocan Pharma distributed 0 USD as dividends.

In which currency does Innocan Pharma pay out the dividend?

The dividends of Innocan Pharma are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Innocan Pharma

Our stock analysis for Innocan Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Innocan Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.